Viewing Study NCT01443650


Ignite Creation Date: 2025-12-24 @ 5:06 PM
Ignite Modification Date: 2025-12-28 @ 4:30 AM
Study NCT ID: NCT01443650
Status: COMPLETED
Last Update Posted: 2013-06-28
First Post: 2011-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Injection Site Tolerability, Safety, Pharmacokinetics, Pharmacodynamics in Different Single-Dose Treatments of Alirocumab SAR236553 (REGN727) in Healthy Subjects
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module